Psychopharmacology and Psychiatry Updates

265 Episoade

1. Association Between Mood Disorders and COVID-19

   Publicat: 16.06.2022
2. Antidepressants and Naltrexone for Stimulant Use Disorder

   Publicat: 11.06.2022
3. CANMAT Task Force Recommendations for the Use of Ketamine

   Publicat: 06.06.2022
4. Stimulant Replacement Therapies for Methamphetamine and Amphetamine Use Disorder

   Publicat: 01.06.2022
5. Premenstrual Mood Syndromes

   Publicat: 27.05.2022
6. Stimulant Use Disorder: Diagnosis and Assessment

   Publicat: 22.05.2022
7. Zuranolone for Postpartum Depression

   Publicat: 17.05.2022
8. Long-Term Treatment of First Episode of Psychosis

   Publicat: 12.05.2022
9. The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia

   Publicat: 07.05.2022
10. Health Issues in First Episode of Psychosis

    Publicat: 02.05.2022
11. Psychopharmacology for Treatment-Resistant Early Psychosis

    Publicat: 27.04.2022
12. Assessing and Treating Adult ADHD

    Publicat: 22.04.2022
13. Medications for Binge Eating Disorder

    Publicat: 17.04.2022
14. Antipsychotics for First Episodes of Psychosis

    Publicat: 12.04.2022
15. Effects on Suicidal Risk With Different Medications

    Publicat: 07.04.2022
16. Risks of Using Cannabinoids

    Publicat: 02.04.2022
17. Lithium: How to Manage Dosage

    Publicat: 28.03.2022
18. CBD as a Medication

    Publicat: 23.03.2022
19. SSRIs and Suicidality

    Publicat: 18.03.2022
20. Cannabis and Cognition

    Publicat: 13.03.2022